Cargando…
The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698111/ https://www.ncbi.nlm.nih.gov/pubmed/31456836 http://dx.doi.org/10.3889/oamjms.2019.569 |
_version_ | 1783444497504403456 |
---|---|
author | Mariko, Rinang Darwin, Eryati Yanwirasti, Yanwirasti Hadinegoro, Sri Rezeki |
author_facet | Mariko, Rinang Darwin, Eryati Yanwirasti, Yanwirasti Hadinegoro, Sri Rezeki |
author_sort | Mariko, Rinang |
collection | PubMed |
description | BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people and 1.298 deaths. AIM: This study aims to analyse differences in angiopoietin-2 levels in dengue hemorrhagic fever (DHF) with and without shock. METHODS: This study was a consecutive sampling design with the research subject was obtained based on the order of admission to the hospital — the serum Angiopoietin-2 levels using the ELISA method. The statistical test used is the independent t-test. The value of p < 0.05 was said to be statistically significant. RESULT: The result showed that the mean of Angiopoietin-2 levels in DHF patients with shock was higher than in DHF (p < 0.05). CONCLUSION: This study concluded that there was a difference in the average level of Angiopoietin-2 among DHF patients with shock compared to without shock. |
format | Online Article Text |
id | pubmed-6698111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Republic of Macedonia |
record_format | MEDLINE/PubMed |
spelling | pubmed-66981112019-08-27 The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock Mariko, Rinang Darwin, Eryati Yanwirasti, Yanwirasti Hadinegoro, Sri Rezeki Open Access Maced J Med Sci Clinical Science BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people and 1.298 deaths. AIM: This study aims to analyse differences in angiopoietin-2 levels in dengue hemorrhagic fever (DHF) with and without shock. METHODS: This study was a consecutive sampling design with the research subject was obtained based on the order of admission to the hospital — the serum Angiopoietin-2 levels using the ELISA method. The statistical test used is the independent t-test. The value of p < 0.05 was said to be statistically significant. RESULT: The result showed that the mean of Angiopoietin-2 levels in DHF patients with shock was higher than in DHF (p < 0.05). CONCLUSION: This study concluded that there was a difference in the average level of Angiopoietin-2 among DHF patients with shock compared to without shock. Republic of Macedonia 2019-07-13 /pmc/articles/PMC6698111/ /pubmed/31456836 http://dx.doi.org/10.3889/oamjms.2019.569 Text en Copyright: © 2019 Rinang Mariko, Eryati Darwin, Yanwirasti Yanwirasti, Sri Rezeki Hadinegoro. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). |
spellingShingle | Clinical Science Mariko, Rinang Darwin, Eryati Yanwirasti, Yanwirasti Hadinegoro, Sri Rezeki The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
title | The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
title_full | The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
title_fullStr | The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
title_full_unstemmed | The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
title_short | The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
title_sort | difference of angiopoietin-2 levels between dengue hemorrhagic fever patients with shock and without shock |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698111/ https://www.ncbi.nlm.nih.gov/pubmed/31456836 http://dx.doi.org/10.3889/oamjms.2019.569 |
work_keys_str_mv | AT marikorinang thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT darwineryati thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT yanwirastiyanwirasti thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT hadinegorosrirezeki thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT marikorinang differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT darwineryati differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT yanwirastiyanwirasti differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock AT hadinegorosrirezeki differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock |